Magnocellular neurosecretory cells (MNCs) in the hypothalamoneurohypophysial system that express and secrete the nonapeptides oxytocin (OT) and vasopressin (VP) were evaluated for the expression of multiple genes in single magnocellular neurons from the rat supraoptic nucleus using a single cell RT-PCR protocol. We found that all cells representing the two major phenotypes, the OT and VP MNCs, express a small, but significant, amount of the other nonapeptide's messenger RNA (mRNA). In situ hybridization histochemical analyses confirmed this observation. A third phenotype, containing equivalent amounts of OT and VP mRNA, was detected in about 19% of the MNCs from lactating female supraoptic nuclei. Analyses of these phenotypes for other coexisting peptide mRNAs (e.g. CRH, cholecystokinin, galanin, dynorphin, and the calcium-binding protein, calbindin) generally confirmed expectations from the literature, but revealed cell to cell variation in their coexpression. Our results also show that the high voltage-activated calcium channel subunit genes, ␣1A-D, ␣2, and ␤1-4 are expressed in virtually all MNCs. However, the ␣1E subunit gene is not expressed at detectable levels in these cells. The expression of all of the ␤-subunit genes in each MNC may account for the variations in physiological and pharmacological properties of the high voltage-activated channels found in these neurons. (Endocrinology 140: [5391][5392][5393][5394][5395][5396][5397][5398][5399][5400][5401] 1999) N EURONAL AND neuroendocrine phenotypes are usually characterized by the specific molecules (e.g. neuropeptides, neurotransmitters, and their associated enzymes) that are consistently expressed in the particular cell type. However, it is now fully accepted that there is significant coexpression of these and other phenotypic markers in neurons, and that subsets of cellular phenotypes with varying coexpression patterns exist in any given neuronal population (1-6). Assessments of such phenotypic variability in neurons has been relatively unexplored due to the limitations of the immunohistochemical (IHC) and in situ hybridization histochemical (ISHH) methodologies that have traditionally been used to assay for expression of specific molecules in cells. IHC and ISHH, especially when performed in double label studies, are nonquantitative and can only detect two (or at the most three) distinct molecules in a given cell. Consequently, these experimental approaches cannot provide insight into the variability of multiple gene expression in neuronal populations. However, the recent use of single cell gene expression profiling approaches has provided new opportunities to address such issues (7-9).
N EURONAL AND neuroendocrine phenotypes are usually characterized by the specific molecules (e.g. neuropeptides, neurotransmitters, and their associated enzymes) that are consistently expressed in the particular cell type. However, it is now fully accepted that there is significant coexpression of these and other phenotypic markers in neurons, and that subsets of cellular phenotypes with varying coexpression patterns exist in any given neuronal population (1) (2) (3) (4) (5) (6) . Assessments of such phenotypic variability in neurons has been relatively unexplored due to the limitations of the immunohistochemical (IHC) and in situ hybridization histochemical (ISHH) methodologies that have traditionally been used to assay for expression of specific molecules in cells. IHC and ISHH, especially when performed in double label studies, are nonquantitative and can only detect two (or at the most three) distinct molecules in a given cell. Consequently, these experimental approaches cannot provide insight into the variability of multiple gene expression in neuronal populations. However, the recent use of single cell gene expression profiling approaches has provided new opportunities to address such issues (7) (8) (9) .
The magnocellular neurosecretory cells (MNCs) in the hypothalamo-neurohypophysial system (HNS) are among the most intensively studied peptidergic neurons in the central nervous system (5, 10 -12) . The MNCs are located primarily in bilateral supraoptic (SON) and paraventricular nuclei (PVN) in the hypothalamus and project their axons to the neurohypophysis, where they secrete the neuropeptides oxytocin (OT) and vasopressin (VP) into the bloodstream as neurohormones. The MNCs have been characterized as having only two distinct phenotypes, the OT and VP magnocellular neurons, in which the expression of the OT and VP genes have been reported to be mutually exclusive (13) . Recently, the presence of a third MNC phenotype expressing both OT and VP has been reported (14, 15) . The OT and VP MNCs also express other neuropeptides [e.g. galanin, cholecystokinin (CCK), CRH, dynorphin, enkephalin, etc.], which can vary depending on specific functional conditions (1, 5, 11, 16) .
The MNCs have served as excellent models for the study of calcium-dependent secretion of neuropeptides from axonal terminals as well as from perikaryonal/dendritic domains (11, (17) (18) (19) (20) (21) (22) (23) . A central issue in this field has been the elucidation of the calcium channel subtypes that subserve the neuropeptide secretion in these different topographic domains in the MNCs (18) . Extensive physiological studies of the diverse calcium channel currents in the MNC somata and axonal terminals have shown that although candidates for all the known subtypes of high voltage-activated (HVA) calcium current can be found in the MNCs, they are distributed heterogeneously in the cell and have different physiological and pharmacological properties depending on their cellular location (18, 22, 23) . Not only is there a differential distri-bution of HVA currents (e.g. somata do not contain Q-type currents, whereas axon terminals do not contain R-type and P-type currents), but the activation thresholds and/or inactivation kinetics of the pharmacologically identified HVA currents (e.g. L-and N-channel subtypes) appear to differ in the two cellular regions.
Given this diversity in the physiological and pharmacological properties of the MNCs, we attempted to determine which of the ␣-and ␤-subunits of the calcium channel complex that are believed to underlie these distinct calcium currents (24 -27) are present in the MNCs. We were particularly concerned with investigating the representation of the various ␤-subunits, as they are known to profoundly modulate the physiological and pharmacological properties of the calcium current carried through ␣-subunit subtypes, but themselves cannot be identified by any known pharmacological agents (28 -34) . Correlating the calcium channel subtypes with the specific MNC phenotypes was an important objective of these studies, and hence, we used a single cell RT-PCR approach to assay for the expression of more than 15 specific genes in each cell.
Materials and Methods

Preparation of single hypothalamic magnocellular neurons
Normal (estrous state undetermined) and lactating female (7-8 days postpartum) Sprague Dawley rats were killed by decapitation. The brains were rapidly removed, placed in HBSS, and trimmed into blocks. Thin horizontal slices (400 m) of ventral hypothalamus, including optic chiasm and tract, were then cut using a tissue chopper. These strips were oxygenated in HBSS for 1 h at room temperature. The supraoptic nucleus surrounding the rostral-lateral margin of the optic tract was dissected, incubated in trypsin for approximately 30 min, washed in low calcium HBSS several times, then gently triturated. The cell suspension was maintained in oxygenated artificial cerebrospinal saline until the cells were collected. Single cells with intact processes were collected with a glass pipette (Fig. 1, inset) and transferred into 4 l lysis buffer. One to 2 l of medium were also transferred in this process.
Lysis and complementary DNA (cDNA) synthesis
Single cells were transferred into 4 l lysis buffer [1 ϫ reverse transcriptase buffer (Life Technologies, Inc., Grand Island, NY), 0.5% Nonidet P-40, 5 m random hexamer primers, 5 U/ml Prime ribonuclease inhibitor (5 Prime-3 Prime, Inc., Boulder, CO), 324 U/ml RNAguard (Pharmacia Biotech, Piscataway, NJ), and 0.5 mm each of deoxy (d)-ATP, dCTP, dGTP, and dTTP] and were used immediately for RT or stored at Ϫ70 C. The cells were lysed at 65 C for 1 min. One hundred units of Superscript II reverse transcriptase (Life Technologies, Inc.) was then added, and the reactants were incubated for 1 h at 37 C. The reverse transcriptase was inactivated by incubation for 10 min at 65 C, and the total volume was brought to 50 l with dH 2 O.
PCR amplification
Amplification of VP and OT was performed as follows. A 50-l hot start PCR reaction was assembled with a 25-l lower reaction mix containing 1 ϫ PCR buffer F (PCR optimization kit, Invitrogen, San Diego, CA), 125 m of each dNTP, and 2.5 pm of each primer (Table 1) . A wax bead was added to the reaction mix, melted at 80 C for 5 min, then allowed to harden at 4 C, forming a barrier on top of the lower reaction mixture. The upper reaction mix contained 1 ϫ buffer F, 0.5 l single cell cDNA template, and 2.5 U Taq polymerase (Perkin-Elmer Corp., Norwalk, CT). Amplification was performed as follows: 40 cycles at 94 C for 45 sec, 62 C for 45 sec, and 72 C for 2 min. After cycling, the reaction was extended at 72 C for 7 min. Three microliters from the 50-l reactions were run on a 1.5% agarose gel containing ethidium bromide and digitally photographed with a Stratagene Eagle Eye camera (La Jolla, CA).
All other amplification reactions were performed as follows. One to 4 l single cell cDNA template were amplified in 20-l reactions containing 1 ϫ PCR buffer (Perkin-Elmer Corp.), 125 m of each dNTP, 2.5 pm of each primer (Tables 1 and 2) , and 2.5 U Taq Polymerase Gold (Perkin-Elmer Corp.). Amplification was performed on a PCR Thermal Cycler 9600 as follows: 1) hold at 94 C for 10 min; 2) 40 cycles at 94 C for 30 sec, 58 C for 30 sec, and 72 C for 2 min; 3) hold at 72 C for 20 min; FIG. 1. OT and VP phenotypes of hypothalamic supraoptic magnocellular neurons were determined by RT-PCR. cDNAs from individual cells were amplified by PCR with primers that are specific for OT, VP, and GAPDH. The PCR products were then run on 1.5% agarose gels containing ethidium bromide. A negative control reaction lacking template DNA is run with every primer set (lane C). A, Single cell RT-PCR products from a nonlactating (normal) female rat. B, Single cell RT-PCR products from a lactating rat. Inset, Photomicrograph of an individual dissociated magnocellular neuron. The harvesting pipette is touching the large cell body, and two large dendrites are evident. Scale bar, 20 m. and then 4) hold at 4 C. Five microliters from the 20-l reactions were run on 1.5% agarose gels containing ethidium bromide and digitally photographed with a Stratagene Eagle Eye camera.
In situ hybridization and immunohistochemistry
Serial 12-m coronal sections were cut on a cryostat microtome and placed onto slides coated with 0.5% gelatin and 0.05% chromium potassium sulfate, dried on a slide warmer at 40 C for 10 -30 min, and then stored at Ϫ70 C. Before hybridization, the sections were fixed at room temperature in 4% formaldehyde for 30 min and in 0.25% acetic anhydride and 0.1% triethanolamine-HCl, pH 8.0, for 10 min, then transferred through graded ethanol and air-dried.
Two different ISHH methods were used in this study. Detailed protocols can be found at the website http://intramural.nimh.nih.gov/ lcmr/snge/. In the first method, oligonucleotides complimentary to either OT-neurophysin (OT-NP) or VP-neurophysin (VP-NP) messenger RNA (mRNA) were used as 35 S-labeled ISHH probes as previously described (35, 36) . These probes had specific activities ranging from 12,000-15,000 Ci/mmol. After the ISHH washes, fluorescent IHC was performed using monoclonal antibodies to either OT-NP (PS-36) or VP-NP (PS-41) (37) . The slides were incubated in primary antibody for 1 h at room temperature at a 1:100 dilution in 1 ϫ PBS (pH 7.2) with 0.6% Triton X-100 to improve penetration. After two rinses, a rhodamineconjugated antimouse IgG was applied (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) at a 1:500 dilution for 1 h at room temperature. After two rinses, the sections were coated in Kodak NTB3 nuclear track emulsion (Eastman Kodak Co., Rochester, NY) and developed 3 weeks later. The sections were then coverslipped and viewed under a Leitz Dialux20 microscope (Rockleigh, NJ).
In the second method, antisense riboprobes were used for ISHH as described by Le Moine and Young (38) . The OT probe was generated from a 476-bp SstI rat genomic fragment containing exon I inserted into the pGEM-3z vector (Promega Corp., Madison, WI). The VP probe was generated from a 229-bp DraI/PstI cDNA fragment targeting the 3Ј-end of the rat VP mRNA, also in pGEM-3z. These probes were used for both single and double labeling experiments. The specific activity of these riboprobes ranged from 64,000-133,000 Ci/mmol. In double labeling experiments, 10 6 cpm 35 S-labeled probe were mixed with 4 l digoxi- 
genin-labeled probe/50 l hybridization solution. After overnight hybridization at 55 C, the sections were washed, processed for the digoxigenin-labeled probe, and apposed to a Kodak AR film overnight. Next, the slides were coated with Ilford K.5D nuclear emulsion and developed 3 months later.
Calcium channel subunit expression analysis
Digitally photographed images of each gel (see Fig. 4A for an example) are analyzed with an image analysis software program developed at NIH (NIH Image version 1.60). Fluorescent intensities were measured as optic density averaged over a fixed area. Optical densities were taken for the 394-, 512/504-, 1,084-, 1,608-, and 2,168-bp bands of the 1-kb ladder DNA marker (Life Technologies, Inc.). Fluorescent intensity for each band was expressed as the measured optical density minus the average of two background measurements. Fluorescent intensity was then plotted against the known mass of each molecular marker band, creating a standard curve for each gel (Fig. 4B ). The masses of the amplified calcium channel subunit cDNAs were then determined from this standard curve. The average mass of each calcium channel subunit cDNA was obtained by adding the mass derived from one to four separate experiments and then dividing by the total template volume analyzed (in microliters). The values shown in Table 3 represent the average mass of calcium channel subunit cDNA divided by the mass of the endogenous glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA.
Statistical analyses of the data were performed using the KruskalWallis and Mann-Whitney U tests (StatView version 5.0, SPSS, Inc., Chicago, IL).
Results
OT and VP phenotype analysis of individual magnocellular neurons
We determined the phenotype of isolated individual magnocellular neurons by evaluating their expression of OT or VP mRNA by RT-PCR. Neurons from the SONs of female Sprague Dawley rats were dissociated, and candidate magnocellular neurons, identified by their large cell bodies and the presence of large dendrites (see inset in Fig. 1 ), were individually collected into a glass micropipette and immediately transferred into a tube containing lysis buffer. The phenotype of each cell was determined by RT-PCR using primers specific for OT and VP mRNAs, and GAPDH primers were used to measure mRNA of this housekeeping gene.
Ten magnocellular neurons from a 90-g normal female (nonlactating) rat were analyzed. Four cells (no. 1-4 in Fig.  1A ) predominantly express VP mRNA (40%) and six cells (no. 5-10 in Fig. 1A ) predominantly expressed OT mRNA (60%). As this RT-PCR assay is sensitive (can detect about 30 copies of OT and VP mRNA; our unpublished observations), but not quantitative (the maximum bands in Fig. 1A are clearly saturated), the absolute levels of OT and VP are unknown. However, these data clearly show that most of the time there was detectable OT mRNA expression in VP cells (i.e. cells expressing predominantly VP mRNA) and VP mRNA expression in OT cells (expressing predominately OT mRNA). The OT and VP cells exhibiting this level of coexistence does not represent the population of magnocellular neurons that has previously been reported in IHC and ISHH experiments to express both OT and VP. That OT-and VPcoexpressing cell population in normal rats has been described as representing only about 1-3% (14, 15) of the total magnocellular neuronal population. The probability of detecting this population of neurons in a sample size of 10 (as in Fig. 1A ) would be negligibly small. In contrast, we found that the coexpression illustrated in Fig. 1A , occurs in the majority of the magnocellular neuronal population in normal rats.
To identify the OT-and VP-coexpressing population that has been described previously by IHC and ISHH, we also studied MNCs from a lactating female SON, where this coexpressing population is reported to be increased to about 18% of the total population (15) . The RT-PCR data from 16 individual magnocellular neurons from a lactating rat are shown in Fig. 1B. Seven cells (no. 1, 3, 8, 9 , 10, 12, and 14 in Fig. 1B ) predominately express VP mRNA (44%), 6 cells (no. 6, 7, 11, 13, 15, and 16 in Fig. 1B ) predominately express OT mRNA (37%), and 3 cells (no. 2, 4, and 5) appear to express VP and OT mRNAs at indistinguishable levels (19%). Thus, this single cell RT-PCR approach detects three phenotypes, previously identified by IHC and ISHH, i.e. OT and VP cells that predominantly express one peptide mRNA species (and small amounts of the opposite mRNAs) as well as an OT/ VP-coexpressing phenotype that appears to express similar levels of the two peptide mRNA species. In the lactating rats, as in normal female rats, lower levels of OT mRNA were typically detected in VP cells and lower levels of VP mRNA were also detected in OT cells (Fig. 1B) .
ISHH evidence for the expression of low levels of the alternative nonapeptide mRNA in the OT and VP phenotypes
The high sensitivity of the RT-PCR procedure revealed for the first time that most of the magnocellular OT and VP phenotypes also expressed lower levels of VP and OT mRNAs, respectively (Fig. 1, A and B) . In another series of studies, which used competitive, quantitative RT-PCR procedures on the single cell mRNAs, we determined that the difference between the major and minor peptide mRNA species in the OT and VP magnocellular phenotypes in normal rat SONs was about 2 orders of magnitude (39) . In contrast in the OT/VP phenotype the difference was about 2-fold. Clearly, the latter mRNA coexistence would be in the detection sensitivity of conventional ISHH using oligonucleotide probes (14, 15) , whereas the predominant (Ͼ70%) coexpression at lower levels was not.
We therefore reasoned that if the RT-PCR data were correct, then by increasing the sensitivity of the ISHH procedure we should be able to detect this more general form of coexpression by ISHH. Figure 2 provides evidence in favor of this view. The expression of OT and VP mRNA in the SON was visualized by two different double labeling techniques. The first method combines conventional ISHH using radiolabeled oligonucleotides and IHC with OT-NP or VP-NP antibodies. The second method combines ISHH using a highly sensitive radiolabeled antisense RNA probe with a less sensitive digoxigenin-labeled RNA probe for double label ISHH.
Using the first (lower sensitivity) technique, cells that were labeled by the OT-NP oligonucleotide (red in Fig. 2A) were located mostly in the dorsal portion of the SON, whereas the VP-NP-immunoreactive cells (green in Fig. 2A ) occupied the ventral region of the SON. Similarly, cells that were labeled by the VP-NP oligonucleotide were located in the ventral portion of the nucleus (red in Fig. 2B ), whereas OT-NP-immunoreactive cells occupied the dorsal region of the SON (green in Fig. 2B ). The absence of yellow cells shows that these findings are consistent with previous conclusions stating that the two populations are distinct and separate (13) .
However, when the more sensitive ribonucleotidebased ISHH technique was employed, most of the magnocellular neurons in the SON contained detectable OT mRNA (Fig. 2C) , and virtually all of the cells contained detectable VP mRNA (Fig. 2D) . The results of the double label ISHH, using high sensitivity probes for minor mRNA species, also confirmed the widespread coexpression of these two peptide mRNA species in the magnocellular neurons. Many VP cells coexpressed OT mRNA (Fig. 2, E and G), and most OT cells coexpressed VP mRNA (Fig. 2,  F and H ). This was difficult to visualize in the brightfield images (Fig. 2, E and F) . However, examination of these cells (rectangles in Fig. 2, E and F) by epifluorescent light using a polarizing filter allowed visualization of the grains even on top of the digoxigenin stain. We also found that the VP neurons in the suprachiasmatic nucleus did not show coexpression of OT mRNA, even with the higher specific activity probe and long exposure times (not shown). Thus, this direct demonstration by ISHH of coexpression of OT and VP mRNA in nearly all magnocellular neurons of the SON serves as a validation of our results obtained using RT-PCR phenotype analysis of dissociated, isolated single cells.
Other coexpressed peptide mRNAs in the magnocellular neurons
In addition to the major neuropeptide genes, OT and VP, prominently expressed in the magnocellular neurons, many other peptide genes are also known to be expressed in these neurons at varying levels depending on specific experimental conditions (1, 5, 16, 40) . From these studies it is generally agreed that in the SONs of normal rats, most VP neurons typically contain detectable levels of dynorphin and galanin, whereas most OT neurons do not. In contrast, a significant number of OT neurons express CCK and CRH peptides, whereas under normal conditions very few, if any, VP neurons do. In addition, calbindin, a calcium-binding cytosolic protein, is more highly represented in OT neurons than VP neurons in the SON (41, 42) . Figure 3 illustrates RT-PCR analyses of 13 cells from lactating and nonlactating rats that strongly express VP or OT, and which were examined for their coexpression of the above peptide mRNAs. The presence of dynorphin, galanin, CRH, CCK, and calbindin mRNAs in individual OT and VP cells was determined by gene-specific RT-PCR (Table 1 ) using 1 l of 50 l total single cell lysate for each reaction. The PCR-amplified product was run on a 1% agarose gel containing ethidium bromide. Results of gene-specific PCR amplification are shown for identified OT cells (Fig. 3A) and VP cells (Fig. 3B) ; the cell numbering is the same as that shown in Fig. 1 .
As expected from the literature (see above), dynorphin mRNA was, in general, more robustly expressed in the VP than the OT neurons in both normal and lactating rats (Fig.  3) . However, heterogeneity in this property was clearly evident, in that one VP neuron (cell 2 in Fig. 3B ) appeared to contain no dynorphin mRNA, and one OT neuron appeared to exhibit a robust expression of dynorphin mRNA (cell 11 in Fig. 3A) . A similar pattern was observed for galanin mRNA, which is believed to be predominately expressed in VP neurons vs. OT neurons. This appears generally to be confirmed by the RT-PCR data in Fig. 3 , as five of six VP neurons exhibited detectable galanin mRNA, whereas in only two of seven OT neurons could galanin mRNA be detected. Again, there was heterogeneity, and the most robust galanin expression occurred in an OT neuron (cell 7 from normal females in Fig. 3A) . A similar pattern was obtained for those peptide mRNAs that are believed to be predominantly represented in OT cells. Calbindin mRNA was expressed at easily detectable levels in five of seven OT cells and generally less intensely in four of six VP cells. CCK mRNA was detected only in the two OT cells from the lactating rat, and CRH mRNA was detected in one of the two OT cells from the lactating rat. Thus, although this RT-PCR analysis of these other coexisting peptide mRNAs confirms the conclusions already present in the literature based on IHC and ISHH data, the individuality of each cell's peptide expression profile (Fig. 3) is dramatically made evident by this single cell RT-PCR analysis.
FIG. 3.
Identified OT and VP hypothalamic supraoptic magnocellular neurons were analyzed for coexpression of several other peptides. cDNAs from individual cells were amplified by PCR with primers specific for GAPDH, dynorphin, galanin, calbindin, CCK, and CRH. The PCR products were then run on 1.5% agarose gels containing ethidium bromide. A negative control reaction lacking template DNA is run with every primer set (lane C). The cells are grouped according to their phenotype (Fig. 1) . A, OT; B, VP.
Calcium channel subunit expression profiles in individual, identified magnocellular neurons
Given the above validation of the single cell RT-PCR approach to determine peptide mRNA expression profiles and cellular identities in the magnocellular neuronal population, we then extended this approach to study the HVA calcium channel subunit mRNAs in these cells. The expression of various ␣ and ␤ HVA calcium channel subunit mRNAs in individual, phenotypically identified, magnocellular neurons was determined using a single cell RT-PCR protocol (see Materials and Methods). Specific primer pairs for the various HVA neuronal calcium channel subunits (see Table 2 ) were used for RT-PCR analysis of 16 individual magnocellular neurons that were isolated from a lactating rat and had previously been identified as VP-, OT-, or VP/OT-expressing cells by RT-PCR. All of the primer pairs shown in Table 2 were pretested using whole rat hippocampal cDNA and were found to be highly effective in generating robust and appropriately sized PCR products.
In these experiments, 1-4 l single cell cDNA template were typically used for PCR analysis. The PCR products were visualized by agarose gel electrophoresis in the presence of ethidium bromide as described previously for the phenotypic and peptide coexpression analyses. In all cases, we observed a single band migrating at the expected mol wt as predicted from the primer positions. A representative example of the raw data obtained from a single cell using several of the calcium channel subtype-specific primers is shown in Fig. 4A . For the cell illustrated in Fig. 4A , the most robust PCR products were from ␣1A-, ␣1D-, and ␤2-subunit mRNAs, with lower, but clearly detectable, PCR products for ␤3 and ␤4. The ␣1B-subunit mRNA was not detected (Fig.  4A ), but ␣1C mRNA was quite abundant in this particular cell (not illustrated). Estimates of the quantity of PCR products shown in Fig. 4A were performed by comparing their fluorescence intensities to the mass values of known standards run in the same electrophoretic run, as shown in Fig.  4B . By converting each cell's PCR products to such nanogram DNA values, it was possible to compare these values between different cells. Table 3 summarizes the calcium channel mRNA expression profiles found in the OT, VP, and OT/VP neuronal phenotypes. The data are shown as PCR product mass for each subunit (nanograms of cDNA; see Fig. 4 ), divided by the PCR product mass of the endogenous GAPDH in each cell, and as an average (mean Ϯ sem) value for the given phenotype. As can be seen from these average values in Table 3 , virtually all of the ␣ and ␤ calcium channel subunit mRNAs were found in both the OT and VP neuronal phenotypes. Only the PCR product from the ␣1E subunit mRNA was consistently absent from all of the phenotypes. This was not due to the inadequacy of the primers used, because amplification of ␣1E mRNA was highly efficient when this primer pair was used with cDNAs obtained from rat brain stem, cerebellum, or hippocampus (not shown). Although all of the calcium channel mRNAs (except for ␣1E) were represented in all of the magnocellular phenotypes, there were significant qualitative and quantitative variations between the individual cell expression patterns, even within a given phenotype (e.g. OT vs. VP). There do seem to be some differential patterns between the phenotypes that are suggested by comparing the average values in Table 3 . The L-channel-associated subunits, ␣1C and ␣1D, were more prominent in the OT vs. the VP phenotype, and ␣1C was absent from the OT/VP phenotype and present at very low levels in the VP phenotype. This absence of ␣1C in the OT/VP cells was compensated for by abundant ␣1D expression in the OT/VP phenotype. As expected, the ␣2-subunit mRNA, which was present in all calcium channel subtypes, was abundantly expressed in all the phenotypes.
The apparent differences in Table 3 between the ␤-subunit mRNAs were not found to be statistically significant (i.e. P Ͼ 0.05). Only the difference in ␣1C between the OT and OT/VP phenotypes was significant (P ϭ 0.04). In summary, the data in Table 3 show that virtually all of the calcium channel subtype mRNAs are expressed in each individual magnocellular neuron, that the levels of expression of any given subunit varies from cell to cell, and that only subtle, if any, differences in expression exist between the phenotypes.
Discussion
Reassessing the MNC phenotype
The earliest studies of the MNCs, using IHC or ISHH techniques, identified only two distinct cellular phenotypes in the HNS, the OT-or the VP-expressing magnocellular neurons (13, 43) . These observations led to the generalization that expression of the OT and VP genes is mutually exclusive (13) . However, there have been subsequent reports of an OTand VP-coexpressing MNC phenotype (14, 15) , which increased in number under specific physiological conditions (15) .
Our studies at the single cell level confirm the existence of an OT/VP-coexisting MNC population in the SON especially during lactation. However, our data also reveal that in control rats, virtually all of the MNCs of the OT phenotype express some VP, and those of the VP phenotype contain OT mRNA. If this coexpression of OT and VP is so widespread in the MNCs, then why was it not previously detected by IHC and ISHH methods? We believe the reason is that in the OT and VP phenotypes the difference in expression level between the major and minor peptides is so great that morphologists are generally reluctant to use conditions that can detect the minor peptide, because these would lead to massive overdevelopment of the major phenotype and, therefore, would obscure the primary cell of interest. Consequently, we tested this idea by performing double label IHC-ISHH in the conventional manner (showing the absence of coexistence) as well as under conditions that could reveal the lower levels of mRNA and the widespread expression predicted by RT-PCR. The results of these ISHH experiments confirm the conclusion of widespread coexpression and suggest that in the OT and VP phenotypes the major peptide mRNA level is much higher than that of the minor peptide. In fact, recent quantitative measurements in our laboratory of the absolute levels of OT and VP mRNAs in single MNCs indicate that the major peptide mRNA is present at 2 orders of magnitude greater levels than the minor peptide mRNA (39) .
It remains to be determined if the minor coexpressed peptide mRNA has a physiological role or if its expression leads to detectable biosynthesis of the peptide in the cell. In any case, these results bear on our understanding of how these genes are regulated. A model based on the premise that these cells exclusively express either OT or VP mRNA would predict that there must be a strong genetic switch regulating the expression of these two genes. In contrast, our data show that the minor expressed peptide gene is activated to a significant basal level with the predominant peptide gene being superactivated above this level. It is also interesting to note that expression of the OT and VP genes is quite variable from cell to cell, suggesting that the expression of OT and VP mRNA is determined dynamically. This cell to cell variability is even more pronounced when considering other coexpressed peptides.
Expression of other peptide mRNAs in MNCs
It is well known that MNCs express peptides other than OT and VP (1, 5, 11, 16, 44 -46) , and that these copeptides are selectively expressed between the two major phenotypes. IHC and ISHH studies have shown that CRH and CCK are coexpressed in OT cells, and galanin and dynorphin are coexpressed in VP cells. Table 3 for summaries of these data.
We used the above information to produce additional validation of our RT-PCR method's ability to assess lower levels of gene expression (these copeptides are generally expressed at 1-2 orders of magnitude lower levels than the major OT and VP mRNAs in the MNCs). In general, our results confirm expectations from the literature. CRH and CCK tend to primarily colocalize to a subset of OT cells, and galanin and dynorphin tend to colocalize to VP cells. However, by analyzing the colocalization of all of these genes in individual cells by gene profiling, we find that considerable variation occurs. For example, we find galanin mRNA predominantly in VP cells, as indicated in the literature; however, the highest level of galanin mRNA is in a single OT cell.
Expression of calcium channel subunit mRNAs in the MNCs
Substantial physiological and pharmacological evidence implicates multiple voltage-gated calcium channel subtypes in the secretion of OT and VP (18, 22, 23) . In the central nervous system, the various HVA calcium channel currents are associated with ␣1 channel subunit proteins encoded by five distinct subunit genes (␣1A, ␣1B, ␣1C, ␣1D, and ␣1E) (24 -27) . IHC and ISHH studies of the distribution of ␣1-subunit mRNA and ␣1-subunit immunoreactivity in the central nervous system suggest that most or all of the identified calcium channel types are expressed in the hypothalamus (17) . However, none of these studies was at cellular resolution in the HNS, and differences in expression between OT and VP cells were not considered. In addition to the five distinct ␣1-subunits discussed above, there are also four distinct ␤-subunits (␤1, ␤2, ␤3, and ␤4) to be considered. The ␤-subunits are of particular interest here, because they are known to modulate the physiological and pharmacological properties of the ␣1-subunits, but they themselves are not selectively sensitive to any known pharmacological agents (28 -32, 34) . In addition, there are very few, if any, good antibodies available that can distinguish among the ␤-subunits in IHC procedures.
The calcium channel subtypes in the somatic and axonal terminal domains of the MNCs have been intensively studied, and the roles of these subtypes in secretion of OT and VP from axonal terminals in the neurohypophysis have also been evaluated by pharmacological agents (18, 23) . Significant differences in the activation thresholds and inactivation times of the specific calcium channel currents in the MNCs were found depending on cellular locations where these parameters were measured (18) . For example, N-type channels in axon terminals rapidly inactivated ( ϭ 100 msec), whereas in somas they inactivated very slowly ( ϭ 1800 msec), and although pharmacologically identified L-channels in somas had relatively low activation thresholds (about Ϫ50 mV), in axonal terminals the L-type channels were activated between Ϫ20 to Ϫ30 mV. In addition to these variations, there are unusual pharmacological sensitivities that have been found for some of the calcium currents (18) . Consequently, we performed a gene expression profile analysis of calcium channel subunit mRNAs.
The data, summarized in Table 3 , show that all of the HVA calcium channel subunit genes, with the exception of ␣1E, are expressed in all of the MNC phenotypes, i.e. the OT, VP, and OT/VP neurons. The absence of ␣1E mRNA is of some interest, as R-type channels have been reported as being present in MNC somata.
The data in Table 3 are expressed as nanograms of gene- All cells are from the supraoptic nucleus of a lactating rat. The cells are classified as OT, VP, and OT/VP according to the phenotypic analysis of these cells shown in Fig. 1B .
a Values represent average nanograms of gene-specific PCR product cDNA per ng GAPDH PCR product (see Fig. 4 and Materials and Methods).
specific PCR product cDNA units normalized to the endogenous GAPDH PCR product. These values can only be compared for a given PCR product (e.g. ␣1A, etc.) between different cells (or phenotypes), but not between PCR products in a given cell (e.g. ␣1A vs. ␣1B, etc.), as the efficiencies of the primer pairs for each specific molecule are unknown and could differ significantly. Determination of absolute mRNA content per cell would require another type of PCR, i.e. quantitative competitive PCR, which was not performed here. Given this restriction it is still possible to compare subunit representations between the MNC phenotypes by focusing on the mean values in Table 3 . In this regard, it is reassuring that the housekeeping gene, GAPDH, had relatively consistent nanograms of cDNA per cell, independent of phenotype. Similarly, the ␣2 calcium channel subunit, which is present in all subtypes of calcium channels, was not significantly different between different cells and phenotypes.
Comparing the mean values of the data and the different phenotypes in Table 3 , it can be seen that the ␣1A-and ␣1B-subunit mRNAs are similarly represented in the OT and VP cells. Similarly, the ␣1C-subunit mRNA levels are not significantly different between the OT cells and the VP cells. Only in the OT cell (but not the VP cell) was the ␣1C-subunit mRNA significantly greater than that in the OT/VP cells (P ϭ 0.04). The ␣1D-subunit also appears to be expressed in all three phenotypes, but possibly at a lower level in the VP phenotype. Especially notable is that all the ␤-subunits were expressed in the MNCs, but not at statistically significantly different levels between the MNC phenotypes.
The data in Table 3 also suggest a significant cell to cell variation in the representation of various subunit mRNAs. All of the cells have substantial levels of GAPDH and ␣2 mRNA; however, most of the other subunit mRNAs are variably expressed from cell to cell. Similar cell to cell variations were reported in a RT-PCR analysis of calcium channel ␣1-subunit mRNAs in single motor neurons of the rat facial nucleus (see Table 2 in Ref. 8) . The significance of this cell to cell variation is unclear, and its clarification will require further RT-PCR and combined physiological experimentation in the same single neurons.
In summary, the single cell RT-PCR experiments described in this paper have shown for the first time that virtually all of the MNCs exhibit OT and VP coexistence, and that all three identifiable MNC phenotypes express all ␣1-subtype calcium channel subunit mRNAs, except for ␣1E. Most important is the demonstration of a widespread expression of all four ␤-subunits in the MNCs. It is therefore possible that by varying the combinations of ␣1A-D and ␤1-4 assemblies in the MNCs and by targeting these different complexes to either soma/dendritic or axon terminal domains, the variations in physiological and pharmacological properties of calcium channels found in these cells can be generated.
